Kyverna Therapeutics

83 people · 0 jobs
‌

Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases.

Employees

11-50

Links


Org chart

Dominic Borie
President, Research & Development
Tom Van Blarcom
SVP & Head, Research
Seshadri Srinivasachari
VP, Program Lead
Jennifer Leslie
Senior Director Medical Affairs
David Moriarty
Vice President Clinical Operations
John Farris
Vp, Head Of Gxp Quality
Sheena Saechao
Associate Director, Finance

Board & advisors

Ian Clark
Chairman
Brian Kotzin
Director
Fred Cohen
Director
Steve Liapis
Director
Georg Schett
Scientific Advisor
Peter A. Merkel
Scientific Advisor
Ignacio Sanz
Scientific Advisor